Cinpharm is owned by a consortium, and started pharmaceutical drug production in 2011. The company produces antibiotics, antifungals, pain killers, and IV fluids following international standards of production called cGMP, which stands for “current Good Manufacturing Practice”.
Currently, Cinpharm is reorganizing and looking for strategic alliances and partners. The company wants to branch into more lucrative specialty pharmaceutical drug markets such as oncology and high blood pressure medication, which are scarcely available in Cameroon.
To Dr. Hodel’s left: Prof. Simon Efange from the University of Buea, and Dr. Issa Hamajodad, former Cinpharm production pharmacist, now with Stride, Cameroon.
Cinpharm has been producing generic pharmaceutical drugs since 2011. The company is currently negotiating a partnership with an international pharmaceutical drug manufacturer. At the same time, Strides (an Indian company) — in collaboration with a Cameroonian pharmacist — is building an even larger company with more manufacturing capacity, also in Douala.
Read the white paper to learn more about drug production and training needs in Cameroon.
Diamond Pharmaceuticals was the first start-up AIDSfreeAFRICA supported. Support has been given in the form of expertise, technology, and microloans. Diamond Pharmaceuticals is currently on hold until their board of directors decides otherwise.
Dr. Gisele Etame is the majority shareholder and is in charge of Genemark. This factory produces children’s syrups to treat coughs, malaria, and fevers/colds. The company wants to expand syrup production to keep up with demand and thereafter to add solid oral drug tablet production. CEO Dr. Etame is successfully expanding production and gaining market shares.
We are fortunate to have intensified our collaboration with the Cameroonian Baptist Convention. They produce sterile IV fluids, eye drops, and ointments for internal use. They recently added drinking water/ bottling capabilities. Thanks in part to Hoffmann-La Roche Technology Transfer Initiative specialist Luc Schnitzler’s visit, the main players in Cameroon’s pharmaceutical production came together to cooperate.